Carl Zeiss Meditec AG (AFX.DE) — the peer cohort

As of 2026-09-17 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Carl Zeiss Meditec AG ranks 7 of 16 in its cohort on the Closelook composite (50/100) — the cohort is led by ASML Holding N.V. at 62/100.

Name	Composite	Momentum	Quality	Valuation	Signal	Off 52w high
AFX.DE Carl Zeiss Meditec AG	50	58	31	63	bull	35.9%
ABBN.SW ABB Ltd	54	57	62	41	watch	12.2%
AIR.PA Airbus Group SE	49	65	41	49	watch	9.7%
AIXA.DE AIXTRON SE	46	29	47	37	bear	45.5%
ALFA.ST Alfa Laval AB	47	57	53	42	bull	7.5%
ARM Arm Holdings plc American Depositary Shares	54	51	65	9	info	46.1%
ASM.AS ASM International NV	57	42	71	29	bear	29.4%
ASML.AS ASML Holding N.V.	62	55	83	22	watch	19.8%
ATCO-A.ST Atlas Copco AB Series A	52	64	63	32	watch	7.8%
ATS.VI AT & S Austria Technologie & Systemtechnik Aktiengesellschaft	39	57	25	39	bull	34.6%
BAS.DE BASF SE	50	65	19	60	bull	4%
BESI.AS BE Semiconductor Industries NV	50	23	84	26	bull	45.5%
BNTX BioNTech SE	37	45	32	56	bull	22.7%
CAP.PA Capgemini SE	48	42	41	88	neutral	31%
CEVI.ST CellaVision AB	54	63	65	37	bull	13.2%
COTN.SW Comet Holding AG	42	51	25	25	bull	28.6%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-17

Quick answers

Who are Carl Zeiss Meditec AG's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: ABB Ltd (ABBN.SW), Airbus Group SE (AIR.PA), AIXTRON SE (AIXA.DE), Alfa Laval AB (ALFA.ST), Arm Holdings plc American Depositary Shares (ARM), ASM International NV (ASM.AS), ASML Holding N.V. (ASML.AS), Atlas Copco AB Series A (ATCO-A.ST) and others.

How does AFX.DE score against its peers?

Carl Zeiss Meditec AG's composite reads 50/100, ranking 7 of 16 in its cohort as of 2026-09-17; the cohort's highest composite is ASML Holding N.V. at 62/100. Closelook scores are research diary readings, not ratings or advice.